Zurcher Kantonalbank (Zurich Cantonalbank) - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$223,566
-30.8%
13,9380.0%0.00%0.0%
Q2 2023$323,083
+1.5%
13,938
+1.7%
0.00%
-50.0%
Q1 2023$318,460
+100.9%
13,709
+25.5%
0.00%
+100.0%
Q4 2022$158,507
-23.4%
10,924
+0.7%
0.00%0.0%
Q3 2022$207,000
+5.1%
10,8460.0%0.00%0.0%
Q2 2022$197,000
-27.8%
10,8460.0%0.00%0.0%
Q1 2022$273,000
-26.2%
10,846
-19.0%
0.00%
-50.0%
Q4 2021$370,000
-2.4%
13,398
+14.2%
0.00%0.0%
Q3 2021$379,000
+6.5%
11,736
+0.7%
0.00%0.0%
Q2 2021$356,000
+1.4%
11,654
+1.2%
0.00%0.0%
Q1 2021$351,000
+99.4%
11,513
+29.7%
0.00%
+100.0%
Q4 2020$176,000
+104.7%
8,877
+33.9%
0.00%0.0%
Q3 2020$86,000
+14.7%
6,6310.0%0.00%0.0%
Q2 2020$75,000
-1.3%
6,631
+25.0%
0.00%0.0%
Q1 2020$76,000
-37.2%
5,305
+18.9%
0.00%0.0%
Q4 2019$121,000
-5.5%
4,4610.0%0.00%0.0%
Q3 2019$128,000
+3.2%
4,4610.0%0.00%0.0%
Q2 2019$124,000
-6.8%
4,461
+11.7%
0.00%0.0%
Q1 2019$133,000
-10.7%
3,994
-22.3%
0.00%0.0%
Q4 2018$149,000
-27.7%
5,137
+14.7%
0.00%
-50.0%
Q3 2018$206,000
+23.4%
4,4770.0%0.00%
+100.0%
Q2 2018$167,000
+57.5%
4,477
+24.9%
0.00%0.0%
Q1 2018$106,000
-13.8%
3,5840.0%0.00%0.0%
Q4 2017$123,000
+6.0%
3,584
+11.3%
0.00%0.0%
Q3 2017$116,000
+39.8%
3,2200.0%0.00%0.0%
Q2 2017$83,000
+72.9%
3,220
+30.2%
0.00%
Q1 2017$48,000
+17.1%
2,4740.0%0.00%
Q4 2016$41,000
-19.6%
2,4740.0%0.00%
-100.0%
Q3 2016$51,000
-23.9%
2,474
+13.7%
0.00%0.0%
Q2 2016$67,000
-17.3%
2,1750.0%0.00%0.0%
Q1 2016$81,000
-13.8%
2,1750.0%0.00%0.0%
Q4 2015$94,000
+248.1%
2,175
+202.5%
0.00%
Q3 2015$27,000
+200.0%
719
+162.4%
0.00%
Q2 2015$9,000
-10.0%
2740.0%0.00%
Q1 2015$10,000
-99.3%
274
-99.3%
0.00%
-100.0%
Q2 2014$1,440,000
-31.4%
37,000
-63.0%
0.04%
-39.1%
Q4 2013$2,098,000
-10.7%
100,0000.0%0.07%
-14.8%
Q3 2013$2,350,000
+191.6%
100,000
+233.3%
0.08%
+189.3%
Q2 2013$806,000
-62.7%
30,000
-64.7%
0.03%
-63.2%
Q1 2013$2,159,000
+126.3%
85,000
+142.9%
0.08%
+100.0%
Q4 2012$954,000
-35.7%
35,000
-36.4%
0.04%
-36.7%
Q3 2012$1,484,000
-23.9%
55,000
-32.9%
0.06%
-31.0%
Q2 2012$1,949,00082,0000.09%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders